Elevated levels of β-endorphin in temporomandibular joint synovial lavage fluid of patients with closed lock

Journal of Orofacial Pain

Volumn 19, Issue 1, 2005, Pages 41-46

  Kajii, Takashi S ^a   Okamoto, Toru ^a   Yura, Sinya ^b   Mabuchi, Akiko ^a   Iida, Junichiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b TONAMI GENERAL HOSPITAL   (Japan)

Author keywords

Endorphin; Arthrocentesis; Synovial fluid; Temporomandibular joint

Indexed keywords

BETA ENDORPHIN; CINCHONINE; OPIATE; SODIUM CHLORIDE;

ADULT; AGED; ARTHROCENTESIS; ARTHROSCOPY; ARTICLE; BONE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LAVAGE; MALE; MANDIBLE CONDYLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; SYMPTOM; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AGED; BETA-ENDORPHIN; CASE-CONTROL STUDIES; DISLOCATIONS; FACIAL PAIN; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INDICATORS AND REAGENTS; MALE; MANDIBULAR CONDYLE; MIDDLE AGED; PAIN MEASUREMENT; QUINOLINES; SEX FACTORS; STATISTICS, NONPARAMETRIC; SYNOVIAL FLUID; SYNOVITIS; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 13544250646     PISSN: 10646655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Milam SB, Schmitz JP. Molecular biology of temporomandibular joint disorders: Proposed mechanisms of disease. J Oral Maxillofac Surg 1995;53:1448-1454.
2. Milam SB, Zardeneta G, Schmitz JP. Oxidative stress and degenerative temporomandibular joint disease: A proposed hypothesis. J Oral Maxillofac Surg 1998;56:214-223.
3. Kopp S. Neuroendocrine, immune, and local responses related to temporomandibular disorders. J Orofac Pain 2001;15:9-28.
4. Hayashi K, Sugisaiki M, Ota S, Tanabe H. μ-Opioid receptor mRNA expression and immunohistochemical localization in the rat temporomandibular joint. Peptides 2002;23:889-893.
5. Bakke M, Hu JW, Sessle BJ. Morphine application to peripheral tissues modulates nociceptive jaw reflex. Neuroreport 1998;9:3315-3319.
6. Denko CW, Aponte J, Gabriel P, Petricevic M. β-Endorphin, immunological and biochemical changes in synovial fluid in rheumatic disorders. Clin Rheumatol 1986;5:25-32.
7. Suzuki N, Yoshino S, Nakamura H. A study of opioid peptides in synovial fluid and synovial tissue in patients with rheumatoid arthritis [in Japanese]. Arerugi 1992;41:615-620.
8. Bender T, Barna I, Geher P. Synovial immunoreactive β-endorphin levels in rheumatoid arthritis and osteoarthritis. Clin Exp Rheumatol 1999;17:630.
9. Yoshino S, Koiwa M, Shiga H, Nakamura H, Higaki M, Miyasaka N. Detection of opioid peptides in synovial tissues of patients with rheumatoid arthritis. J Rheumatol 1992;19:660-661.
10. Stein C, Hassan AH, Lehrberger K, Giefing J, Yassouridis A. Local analgesic effect of endogenous opioid peptides. Lancet 1993;342:321-324.
11. Przewlocki R, Hassan AH, Lason W, Epplen C, Herz A, Stain C. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: Functional role in antinociception. Neuroscience 1992;48:491-500.
12. Takeba Y, Suzuki N, Kaneko A, Asai T, Sakane T. Endorphin and enkephalin ameliorate excessive synovial cell functions in patients with rheumatoid arthritis. J Rheumatol 2001;28:2176-2183.
13. Soderlund A, Boreus LO, Westman L, Engstrom B, Valentin A, Ekblom A. A comparison of 50, 100 and 200 mg of intra-articular pethidine during knee joint surgery, a controlled study with evidence for local demethylation to norpethidine. Pain 1999;80:229-238.
14. Stein A, Yassouridis A, Szopko C, Helmke K, Stein C. Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 1999;83:525-532.
15. Bryant CJ, Harrison SD, Hopper C, Harris M. Use of intra-articular morphine for postoperative analgesia following TMJ arthroscopy. Br J Oral Maxillofac Surg 1999;37:391-396.
16. Furst IM, Kryshtalskyj B, Weinberg S. The use of intra-articular opioids and bupivacaine for analgesia following temporomandibular joint arthroscopy: A prospective, randomized trial. J Oral Maxillofac Surg 2001;59:979-983.
17. List T, Tegelberg Ä, Haraldson T, Isacsson G. Intra-articular morphine as analgesic in temporomandibular joint arthralgia/osteoarthritis. Pain 2001;94:275-282.
18. Cai BBY, Cairns BE, Sessle BJ, Hu JW. Sex-related suppression of reflex jaw muscle activity by peripheral morphine but not GABA. Neuroreport 2001;12:3457-3460.
19. Bragdon EE, Light KC, Costello NL, et al. Group differences in pain modulation: Pain-free women compared to pain-free men and to women with TMD. Pain 2002;96:227-237.
20. Kubota E, Imamura H, Kubota T, Shibata T, Murakami K. Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 1997;55:20-27.
21. Mabuchi A, Yura S, Ooi K, et al. Incidence of disc deformity and bone changes in patients with anterior disc displacement without reduction of the temporomandibular joint: Comparison among different age groups. J Jpn Soc TMJ 2003;15:13-17.
22. Yu X-M, Sessle BJ, Vernon H, Hu JW. Administration of opiate antagonist naloxone induces recurrence of increased jaw muscle activities related to inflammatory irritant application to rat temporomandibular joint region. J Neurophysiol 1994;72:1430-1433.
23. Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med 1995;332:1685-1690.
24. Okeson JP (ed). Orofacial Pain, Guidelines for Assessment, Diagnosis, and Management. Chicago: Quintessence, 1996:131.
25. Murakami KI, Shibata T, Kubota E, Maeda H. Intra-articular levels of prostaglandin E2, hyaluronic acid, and chondroitin-4 and -6 sulfates in the temporomandibular joint synovial fluid of patients with internal derangement. J Oral Maxillofac Surg 1998;56:199-203.
26. Alstergren P, Kopp S. Prostaglandin E2 in temporomandibular joint synovial fluid and its relation to pain and inflammatory disorders. J Oral Maxillofac Surg 2000;58:180-186.
27. Kajii T, Suzuki K, Yoshikawa M, Imai T, Matsumoto A, Nakamura S. Long-term effects of prostaglandin E2 on the mineralization of a clonal osteoblastic cell line (MC3T3-E1). Arch Oral Biol 1999;44:233-241.
28. Kest B, Sarton E, Dahan A. Gender differences in opioid-mediated analgesia: Animal and human studies. Anesthesiology 2000;93:539-547.
29. Bereiter DA, Bereiter DF, Ramos M. Vagotomy prevents morphine-induced reduction in Fos-like immunoreactivity in trigeminal spinal nucleus produced after TMJ injury in a sex-dependent manner. Pain 2002;96:205-213.